Why the study?
Does intravenous glucagon improve cardiac output and pulmonary vascular resistance in patients after mitral valve replacement?
Population
6 patients who had undergone mitral valve replacement
Design
Case_series
Follow-up
30 minutes
Authors
Loading...
Hypothesis-generating for glucagon post-MVR; randomized trials needed before any practice consideration.
Does intravenous glucagon improve cardiac output and pulmonary vascular resistance in patients after mitral valve replacement?
Intravenous glucagon significantly improves cardiac output and reduces pulmonary vascular resistance in the immediate postoperative period following mitral valve replacement.
Smith et al. (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: